Moss, 15 November 2017
Gentian Diagnostics AS announces its results for the third quarter. The highlights of the quarter include:
- 66% growth in sales revenue compared to 3Q16, 16 % y/y
- New patent protection received after end of period
Please find the report for the third quarter enclosed. The
report will also be made available on www.gentian.no.
For further information, please contact:
Bård Sundrehagen
CEO, Gentian Diagnostics
E-mail: Bard.sundrehagen@gentian.no
Cell Phone: +47 924 14 117